About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [170 citations: 1–100 of 169 articles]

Articles published in Chemotherapy Research and Practice have been cited 170 times. The following is a list of the 169 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, and Aeree Kim, “Role of erbB3 receptors in cancer therapeutic resistance,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 3, pp. 190–198, 2014. View at Publisher · View at Google Scholar
  • Margherita Ratti, “Emerging combination therapies to overcome resistance in EGFR-driven tumors,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 127–139, 2014. View at Publisher · View at Google Scholar
  • Sandhya V. G. Nair, Menik Hettihewa, and H. P. Vasantha Rupasinghe, “Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Rajiv P. Gude, “Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 93–99, 2014. View at Publisher · View at Google Scholar
  • Liyan Jiang, Wei Zhu, Katie Streicher, Chris Morehouse, Philip Brohawn, Xiaoxiao Ge, Zhengwei Dong, Xiaolu Yin, Guanshan Zhu, Yi Gu, Koustubh Ranade, Brandon W. Higgs, and Jiaqi Huang, “Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lo wer epithelial-mesenchymal transition signature and longer survival in squa mous cell lung carcinoma,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Malgorzata K. Tuxen, and Dorte Lisbet Nielsen, “A systematic review of dual targeting in HER2-positive breast cancer,” Cancer Treatment Reviews, vol. 40, no. 2, pp. 259–270, 2014. View at Publisher · View at Google Scholar
  • Dalila Naci, and Fawzi Aoudjit, “Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways,” Cellular Signalling, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Marta Castiglia, Sergio Rizzo, Francesca Lo Vullo, Eugenio Fiorentino, and Jan Van Meerbeeck, “Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clini cal aspects,” Critical Reviews in Oncology Hematology, vol. 89, no. 2, pp. 300–313, 2014. View at Publisher · View at Google Scholar
  • Yuan Zhang, Yukun Liu, Qingmei Liu, Xiaoyan Wang, Zhi Li, and Jie Hao, “In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics Against Multidrug-Resistant Clinical Isolates,” Current Microbiology, vol. 68, no. 6, pp. 685–692, 2014. View at Publisher · View at Google Scholar
  • Megan Lyle, and Georgina V. Long, “The role of systemic therapies in the management of melanoma brain metastases,” Current Opinion in Oncology, vol. 26, no. 2, pp. 222–229, 2014. View at Publisher · View at Google Scholar
  • K. Chanprapaph, V. Vachiramon, and P. Rattanakaemakorn, “Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management,” Dermatology Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Hale Colakoglu Er, N. Ozlem Kucuk, and Ethem Gecim, “Correlation of minimum apparent diffusion coefficient with maximum standard ized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarci noma,” Diagnostic and Interventional Radiology, vol. 20, no. 2, pp. 105–109, 2014. View at Publisher · View at Google Scholar
  • Cheng-Cheung Chen, Dar-Shih Hsieh, Kao-Jean Huang, Yi-Lin Chan, Po-Da Hong, and Ming-Kung Yeh-, “Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanopa rticles in murine B16F10 melanoma cells,” Drug Design Development and Therapy, vol. 8, pp. 459–473, 2014. View at Publisher · View at Google Scholar
  • Fatima el Bahhaj, Frank J. Dekker, Nadine Martinet, and Philippe Bertrand, “Delivery of epidrugs,” Drug Discovery Today, 2014. View at Publisher · View at Google Scholar
  • Mi Ryoung Choi, and Nam Jin Yoo, “Oncogenic ERBB3 mutations altering p.Val104 is rare in acute leukemias and non-Hodgkin lymphomas,” European Journal of Haematology, vol. 92, no. 2, pp. 177–178, 2014. View at Publisher · View at Google Scholar
  • Aleksandar Savić, Lana Filipović, Sandra Aranđelović, Biljana Dojčinović, Siniša Radulović, Tibor J. Sabo, and Sanja Grgurić-Šipka, “Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes,” European Journal of Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Poonam Sharma, Pawas Goswami, Vikas Sangwan, and Rameshwar Singh, “Antibiotic resistance among commercially available probiotics,” Food Research International, vol. 57, pp. 176–195, 2014. View at Publisher · View at Google Scholar
  • Stephanie Shishido, Halvard Bönig, and Yong-Mi Kim, “Role of Integrin Alpha4 in Drug Resistance of Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Zhongbo Hu, and William B. Slayton, “Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Valeria Ferretti, Marco Fogagnolo, Andrea Marchi, Lorenza Marvelli, Fabio Sforza, and Paola Bergamini, “Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents,” Inorganic Chemistry, pp. 140506130435009, 2014. View at Publisher · View at Google Scholar
  • Yang Xiang, Xirun Wan, Fengzhi Feng, and Tong Ren, “Analysis of the Prognosis and Related Factors for Patients With Stage IV Ge stational Trophoblastic Neoplasia,” International Journal of Gynecological Cancer, vol. 24, no. 3, pp. 594–599, 2014. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma,” International Journal of Pharmaceutics, 2014. View at Publisher · View at Google Scholar
  • Gershon Volpin, Miri Cohen, Michael Assaf, Tamar Meir, Rina Katz, and Shimon Pollack, “Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients,” International Orthopaedics, 2014. View at Publisher · View at Google Scholar
  • Anthony Kodzo-Grey Venyo, “Primary Clear Cell Carcinoma of the Urinary Bladder,” International Scholarly Research Notices, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Shutao Guo, Lei Miao, and Yuhua Wang, “Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy,” Journal of Controlled Release, vol. 174, pp. 137–142, 2014. View at Publisher · View at Google Scholar
  • Farshad Homayouni Moghadam, Maryam Dehghan, Ehsan Zarepur, Reyhaneh Dehlavi, Fatemeh Ghaseminia, Shima Ehsani, Golnaz Mohammadzadeh, and Kazem Barzegar, “Oleo gum resin of Ferula assa-foetida L. ameliorates peripheral neuropathy in mice,” Journal of Ethnopharmacology, 2014. View at Publisher · View at Google Scholar
  • Jeremy Rees, “Updates in the management of high-grade glioma,” Journal of Neurology, vol. 261, no. 4, pp. 651–654, 2014. View at Publisher · View at Google Scholar
  • Emanuela Binello, Elisabetta Mormone, Luni Emdad, Harini Kothari, and Isabelle M. Germano, “Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Jian Ma, Hui Lyu, and Jingcao Huang, “Targeting of erbB3 receptor to overcome resistance in cancer treatment,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Shikha Gaur, Linling Chen, Vincent Ann, Wei-Chen Lin, Yafan Wang, Vincent H. S. Chang, Nan Yong Hsu, and Her-Shuyong Shia, “Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutati on status,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, and Jean-Marie Stephan, “Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers,” Molecular Diagnosis & Therapy, vol. 18, no. 2, pp. 137–151, 2014. View at Publisher · View at Google Scholar
  • Gagan Deep, Rahul Kumar, Anil K. Jain, Chapla Agarwal, and Rajesh Agarwal, “Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • Supratim Ghosh, Kamil B. Ucer, Ralph D'Agostino, Ken Grant, Joseph Sirintrapun, Michael J. Thomas, Roy Hantgan, and Manish Bharadwaj, “Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity,” Nanomedicine-Nanotechnology Biology and Medicine, vol. 10, no. 2, pp. 451–461, 2014. View at Publisher · View at Google Scholar
  • Marjo-Riitta Puumalainen, Davor Lessel, Peter Ruethemann, Nina Kaczmarek, Karin Bachmann, and Hanspeter Naegeli, “Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity,” Nature Communications, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Senthilvelan Manohar, and Samson Jamesdaniel, “Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes,” Neurotoxicity Research, vol. 25, no. 4, pp. 369–380, 2014. View at Publisher · View at Google Scholar
  • Haydar Ali Erken, Emine Rabia Koç, Haşmet Yazıcı, Arzu Yay, Gözde Özge Önder, and Saim Furkan Sarıcı, “Selenium Partially Prevents Cisplatin-Induced Neurotoxicity: A Preliminary Study,” NeuroToxicology, 2014. View at Publisher · View at Google Scholar
  • Yongshan Yao, Shenghan Chen, Xin Zhou, and Li Xie, “5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells,” Oncology Letters, vol. 7, no. 2, pp. 541–547, 2014. View at Publisher · View at Google Scholar
  • Kunihiko Fukuchi, Yohei Yamazaki, Hiromi Takayasu, Sakiko Tazawa, Hidetsugu Tateno, Eisuke Kato, Aya Wakabayashi, Mami Fujimori, Takuya Iwasaki, Makoto Hayashi, Yutaka Tsuchiya, Jun Yamashita, Norikazu Takeda, and Fumio Kokubu, “Acquired resistance L747S mutation in an epidermal growth factor receptor-t yrosine kinase inhibitor-na ve patient: A report of three cases,” Oncology Letters, vol. 7, no. 2, pp. 357–360, 2014. View at Publisher · View at Google Scholar
  • Tracey Rowlands, “The Met receptor tyrosine kinase: A key player in oncogenesis and drug resi stance,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 316–338, 2014. View at Publisher · View at Google Scholar
  • Carmine Pinto, Nicola Normanno, Lorenzo Capussotti, Francesco Cognetti, Alfredo Falcone, and Lorenzo Mantovani, “KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Farah Khalil, and Scott Antonia, “PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells ,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Shu-Han Wu, Kuang-Li Lee, Ruei-Hung Weng, Zhao-Xian Zheng, and Arthur Chiou, “Dynamic Monitoring of Mechano-Sensing of Cells by Gold Nanoslit Surface Pla smon Resonance Sensor,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Milo Stanisic, “The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Sub dural Hematoma Patients Assessed with Factor Analysis,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Dimitra Aivazi, Ioannis Kostopoulos, Helen P. Kourea, George Kouvatseas, Eleni Timotheadou, Pantelis Zebekakis, Ioannis Efstratiou, Helen Gogas, Chrisanthi Vamvouka, Sofia Chrisafi, Anastasios Stofas, George Pentheroudakis, Angelos Koutras, Eleni Galani, Dimitrios Bafaloukos, and George Fountzilas, “Differential Expression of the Insulin-Like Growth Factor Receptor among Ea rly Breast Cancer Subtypes,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Naama Kanarek, Sergei I. Grivennikov, Michael Leshets, Audrey Lasry, Irit Alkalay, Elad Horwitz, Yoav D. Shaul, Matthew Stachler, Elena Voronov, Ron N. Apte, Michele Pagano, Eli Pikarsky, Sankar Ghosh, and Yinon Ben-Neriah, “Critical role for IL-1 beta in DNA damage-induced mucositis,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 6, pp. E702–E711, 2014. View at Publisher · View at Google Scholar
  • Koji Taniguchi, and Michael Karin, “IL-6 and related cytokines as the critical lynchpins between inflammation and cancer,” Seminars in Immunology, 2014. View at Publisher · View at Google Scholar
  • Deirdre R. Pachman, James C. Watson, Maryam B. Lustberg, Nina D. Wagner-Johnston, Alexandre Chan, Larry Broadfield, Yin Ting Cheung, Christopher Steer, Dawn J. Storey, Kavita D. Chandwani, Judith Paice, Pascal Jean-Pierre, Jeong Oh, Jayesh Kamath, Marie Fallon, Herwig Strik, Susanne Koeppen, and Charles L. Loprinzi, “Management options for established chemotherapy-induced peripheral neuropathy,” Supportive Care in Cancer, 2014. View at Publisher · View at Google Scholar
  • Guang-Ning Yan, Lang Yang, Yang-Fan Lv, Yu Shi, Li-Li Shen, Xiao-Hong Yao, Qiao-Nan Guo, Peng Zhang, You-Hong Cui, Xia Zhang, Xiu-Wu Bian, and De-Yu Guo, “Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway,” The Journal of Pathology, 2014. View at Publisher · View at Google Scholar
  • Sai-Mei Hou, Goran Pershagen, N. Peter Wiklund, Fredrik Nyberg, and Petra J. de Verdier, “The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers,” Tumor Biology, vol. 35, no. 5, pp. 4425–4434, 2014. View at Publisher · View at Google Scholar
  • Theresa M. Allen, and Pieter R. Cullis, “Liposomal drug delivery systems: From concept to clinical applications,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar
  • Hardeep S. Oberoi, Natalia V. Nukolova, Alexander V. Kabanov, and Tatiana K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, 2013. View at Publisher · View at Google Scholar
  • Andrew T. Chan, Reiko Nishihara, Charles S. Fuchs, Edward Giovannucci, Teppei Morikawa, Aya Kuchiba, Paul Lochhead, Kaori Shima, Ichiro Kawachi, Zhi Rong Qian, Mai Yamauchi, Xiaoyun Liao, Yu Imamura, and Katsuhiko Nosho, “A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification,” American Journal Of Epidemiology, vol. 178, no. 1, pp. 84–100, 2013. View at Publisher · View at Google Scholar
  • Ina Hohensee, Volkmar Mueller, Klaus Pantel, Sabine Riethdorf, Jakob Matschke, Manfred Westphal, Katrin Lamszus, Soenke Meyer-Staeckling, Isabell Witzel, Markus Glatzel, and Burkhard Brandt, “Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Ca ncer Brain Metastases,” American Journal Of Pathology, vol. 183, no. 1, pp. 83–95, 2013. View at Publisher · View at Google Scholar
  • Lifu Xiao, Mingjie Tang, Qifei Li, and Anhong Zhou, “Non-invasive detection of biomechanical and biochemical responses of human lung cells to short time chemotherapy exposure using AFM and confocal Raman spectroscopy,” Analytical Methods, vol. 5, no. 4, pp. 874–879, 2013. View at Publisher · View at Google Scholar
  • S. Roy, H. L. McLeod, L. S. Clark, A. Drobish, L. A. Carey, A. A. Motsinger-Reif, and E. C. Dees, “CYP2C8*3 increases risk of neuropathy in breast cancer patients treated wit h paclitaxel,” Annals Of Oncology, vol. 24, no. 6, pp. 1472–1478, 2013. View at Publisher · View at Google Scholar
  • S. Kim, M. Jary, L. Mansi, B. Benzidane, A. Cazorla, M. Demarchi, T. Nguyen, A. Kaliski, E. Delabrousse, F. Bonnetain, P. Letondal, J. F. Bosset, and S. Valmary-Degano, “DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising t reatment for recurrent advanced squamous cell anal carcinoma,” Annals of Oncology, vol. 24, no. 12, pp. 3045–3050, 2013. View at Publisher · View at Google Scholar
  • Antonio Ruggiero, Giovanna Trombatore, Silvia Triarico, Roberta Arena, Pietro Ferrara, Maria Scalzone, Filomena Pierri, and Riccardo Riccardi, “Platinum compounds in children with cancer,” Anti-Cancer Drugs, vol. 24, no. 10, pp. 1007–1019, 2013. View at Publisher · View at Google Scholar
  • Senthilnathan Rajendran, and Rajendran Shanmugam Muthupalani, “Lack of RING Finger Domain (RFD) Mutations of the c-Cbl Gene in Oral Squamo us Cell Carcinomas in Chennai, India,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 2, pp. 1073–1075, 2013. View at Publisher · View at Google Scholar
  • Zahra Bahadoran, Zeinab Karimi, Anahita Houshiar-rad, and Hamid-Reza Mirzayi, “Dietary Phytochemical Index and the Risk of Breast Cancer: A Case Control S tudy in a Population of Iranian Women,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 2747–2751, 2013. View at Publisher · View at Google Scholar
  • Meltem Demirel Kars, Ufuk Gündüz, Kamil Üney, and Ahmet Levent BaŞ, “Exploring a natural MDR reversal agent: potential of medicinal food supplement Nerium oleander leaf distillate,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 8, pp. 644–649, 2013. View at Publisher · View at Google Scholar
  • Chuchard Punsawad, “Effect of malaria components on blood mononuclear cells involved in immune response,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 9, pp. 751–756, 2013. View at Publisher · View at Google Scholar
  • Takashi Hoshiba, and Masaru Tanaka, “Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages,” Biochemical and Biophysical Research Communications, 2013. View at Publisher · View at Google Scholar
  • Gyoergy Varady, Judit Cserepes, Adrienn Nemeth, and Edit Szabo, “Cell surface membrane proteins as personalized biomarkers: where we stand a nd where we are headed,” Biomarkers in Medicine, vol. 7, no. 5, pp. 803–819, 2013. View at Publisher · View at Google Scholar
  • Dionysis Papadatos-Pastos, Aspasia Soultati, and Mark Harries, “Targeting Brain Metastases in Patients with Melanoma,” BioMed Research International, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Dan Cao, Ye Chen, Yuan Tang, Xing-Chen Peng, Hang Dong, Long-Hao Li, Ke Cheng, Jun Ge, and Ji-Yan Liu, “Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Kari-Elise T. Codispoti, Stacy Mosier, Robert Ramsey, Ming-Tseh Lin, and Fausto J. Rodriguez, “Genetic and pathologic evolution of early secondary gliosarcoma,” Brain Tumor Pathology, 2013. View at Publisher · View at Google Scholar
  • Cynthia X. Ma, Vera J. Suman, Matthew Goetz, Paul Haluska, Timothy Moynihan, Rita Nanda, Olufunmilayo Olopade, Timothy Pluard, Zhanfang Guo, Helen X. Chen, Charles Erlichman, Matthew J. Ellis, and Gini F. Fleming, “A phase I trial of the IGF-1R antibody Cixutumumab in combination with tems irolimus in patients with metastatic breast cancer,” Breast Cancer Research and Treatment, vol. 139, no. 1, pp. 145–153, 2013. View at Publisher · View at Google Scholar
  • Ingar Seemann, Johannes A. M. te Poele, Ji-Ying Song, Saske Hoving, and Nicola S. Russell, “Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents,” Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 385–395, 2013. View at Publisher · View at Google Scholar
  • M. Fujita, T. Kimura, K. Ogawa, C. P. Morrow, S. Kamiura, S. Mabuchi, M. Okazawa, Y. Matsumoto, and T. Tsutsui, “Utility of risk-weighted surgical-pathological factors in early-stage cervi cal cancer,” British Journal Of Cancer, vol. 108, no. 6, pp. 1348–1357, 2013. View at Publisher · View at Google Scholar
  • D. Gonzalez, L. Fearfield, P. Nathan, P. Taniere, A. Wallace, E. Brown, C. Harwood, J. Marsden, and S. Whittaker, “BRAF mutation testing algorithm for vemurafenib treatment in melanoma: reco mmendations from an expert panel,” British Journal of Dermatology, vol. 168, no. 4, pp. 700–707, 2013. View at Publisher · View at Google Scholar
  • Junya Zhu, Dhruv B. Sharma, Aileen B. Chen, Bruce E. Johnson, Jane C. Weeks, and Deborah Schrag, “Comparative effectiveness of three platinum-doublet chemotherapy regimens i n elderly patients with advanced nonsmall cell lung cancer,” Cancer, vol. 119, no. 11, pp. 2048–2060, 2013. View at Publisher · View at Google Scholar
  • Lixia Ju, “Integrin beta 1 enhances the epithelial-mesenchymal transition in associati on with gefitinib resistance of non-small cell lung cancer,” Cancer Biomarkers, vol. 13, no. 5, pp. 329–336, 2013. View at Publisher · View at Google Scholar
  • Lawrence H. Cheung, Walter N. Hittelman, Hideo Yagita, Jeffrey A. Winkles, Hong Zhou, and Stuart S. Martin, “Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Posi tive Solid Tumors,” Cancer Research, vol. 73, no. 14, pp. 4439–4450, 2013. View at Publisher · View at Google Scholar
  • Iris Eke, Katja Storch, and Mechthild Krause, “Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Induci ng Fibronectin Biosynthesis,” Cancer Research, vol. 73, no. 19, pp. 5869–5879, 2013. View at Publisher · View at Google Scholar
  • D. C. Coraca-Huber, J. Hausdorfer, M. Fille, M. Steidl, and M. Nogler, “Effect of two cleaning processes for bone allografts on gentamicin impregna tion and in vitro antibiotic release,” Cell and Tissue Banking, vol. 14, no. 2, pp. 221–229, 2013. View at Publisher · View at Google Scholar
  • Valeria Maria Piccolini, Maria Grazia Bottone, Giovanni Bottiroli, Sandra Angelica De Pascali, and Francesco Paolo Fanizzi, “Platinum drugs and neurotoxicity: effects on intracellular calcium homeosta sis,” Cell Biology and Toxicology, vol. 29, no. 5, pp. 339–353, 2013. View at Publisher · View at Google Scholar
  • Samarth Hegde, “A Skin-depth Analysis of Integrins: Role of the Integrin Network in Health and Disease,” Cell Communication and Adhesion, vol. 20, no. 6, pp. 155–169, 2013. View at Publisher · View at Google Scholar
  • Bruna Corominas-Faja, Cristina Oliveras-Ferraros, Elisabet Cuyas, Antonio Segura-Carretero, Jorge Joven, Begona Martin-Castillo, Enrique Barrajon-Catalan, Vicente Micol, and Joaquim Bosch-Barrera, “Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell l ung cancer A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin,” Cell Cycle, vol. 12, no. 21, pp. 3390–3404, 2013. View at Publisher · View at Google Scholar
  • C. R. I. Lam, C. Tan, Z. Teo, C. Y. Tay, T. Phua, Y. L. Wu, P. Q. Cai, L. P. Tan, X. Chen, and P. Zhu, “Loss of TAK1 increases cell traction force in a ROS-dependent manner to dri ve epithelial-mesenchymal transition of cancer cells,” Cell Death & Disease, vol. 4, 2013. View at Publisher · View at Google Scholar
  • S Wansleben, E Davis, J Peres, and S Prince, “A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance,” Cell Death and Disease, vol. 4, no. 10, pp. e846, 2013. View at Publisher · View at Google Scholar
  • Fereshteh Mir Mohammadrezaei, Homa Mohseni Kouchesfehani, Hamed Montazeri, Mehdi Gharghabi, Seyed Nasser Ostad, and Mohammad Hossein Ghahremani, “Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhib ition in MCF-7 cells,” Cellular Signalling, vol. 25, no. 1, pp. 126–132, 2013. View at Publisher · View at Google Scholar
  • Dana S. Neel, and Trever G. Bivona, “Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT,” Clinical Cancer Research, vol. 19, no. 1, pp. 3–5, 2013. View at Publisher · View at Google Scholar
  • Cynthia Harrison, “Neurologic Complications of Cancer and Cancer Therapy,” Clinical Journal Of Oncology Nursing, vol. 17, no. 4, pp. 418–424, 2013. View at Publisher · View at Google Scholar
  • Tony K. L. Kiang, Kyle J. Wilby, and Mary H. H. Ensom, “Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals,” Clinical Pharmacokinetics, 2013. View at Publisher · View at Google Scholar
  • Vladimir P. Chekhonin, Anna A. Korchagina, Sergey A. Shein, and Olga I. Gurina, “VEGF in Tumor Progression and Targeted Therapy,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 423–443, 2013. View at Publisher · View at Google Scholar
  • P. Warnault, G. Cheve, C. Bories, M. Coisy-Quivy, R. Benhida, A. Yasri, and B. Fauvel, “Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibito rs,” Current Medicinal Chemistry, vol. 20, no. 16, pp. 2043–2067, 2013. View at Publisher · View at Google Scholar
  • Manuel Diezi, and Thierry Buclin, “Toxic and drug-induced peripheral neuropathies: updates on causes, mechanis ms and management,” Current Opinion in Neurology, vol. 26, no. 5, pp. 481–488, 2013. View at Publisher · View at Google Scholar
  • Nicolas Authier, Vanessa Pereira, Jeremy Ferrier, and Jerome Busserolles, “Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy,” Current Pain And Headache Reports, vol. 17, no. 10, 2013. View at Publisher · View at Google Scholar
  • Devron R. Shah, Rashmi R. Shah, and Joel Morganroth, “Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicat ors of Efficacy,” Drug Safety, vol. 36, no. 6, pp. 413–426, 2013. View at Publisher · View at Google Scholar
  • Andrew D. Norden, Eudocia Q. Lee, Rameen Beroukhim, Lakshmi Nayak, Patrick Y. Wen, and Mikael L. Rinne, “Update on bevacizumab and other angiogenesis inhibitors for brain cancer,” Expert Opinion On Emerging Drugs, vol. 18, no. 2, pp. 137–153, 2013. View at Publisher · View at Google Scholar
  • Hebatallah Hassan, Burkhard Greve, Mauro S. G. Pavao, Ludwig Kiesel, Sherif A. Ibrahim, and Martin Goette, “Syndecan-1 modulates beta-integrin-dependent and interleukin-6-dependent fu nctions in breast cancer cell adhesion, migration, and resistance to irradi ation,” Febs Journal, vol. 280, no. 10, pp. 2216–2227, 2013. View at Publisher · View at Google Scholar
  • Mohammad Waseem, “Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory r ole of curcumin,” Food And Chemical Toxicology, vol. 53, pp. 334–342, 2013. View at Publisher · View at Google Scholar
  • Jodee L. Johnson, and Elvira Gonzalez de Mejia, “Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro,” Food and Chemical Toxicology, 2013. View at Publisher · View at Google Scholar
  • Miguel Gueimonde, Borja Sanchez, and Clara G. de los Reyes-Gavilan, “Miguel Gueimonde, Borja Sonchez, Clara G. de los Reyes-Gavilan and Abelardo Margolies,” Frontiers in Microbiology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Satu Maki-Nevala, Virinder Kaur Sarhadi, Katja Tuononen, Sonja Lagstrom, Pekka Ellonen, Mikko Ronty, Aino Wirtanen, and Aija Knuuttila, “Mutated Ephrin Receptor Genes in Non-Small Cell Lung Carcinoma and Their Oc currence with Driver Mutations-Targeted Resequencing Study on Formalin-Fixe d, Paraffin-Embedded Tumor Material of 81 Patients,” Genes Chromosomes & Cancer, vol. 52, no. 12, pp. 1141–1149, 2013. View at Publisher · View at Google Scholar
  • R. DeMasi, Y. van Delft, and P. Mohammed, “Pharmacokinetic interaction between etravirine or darunavir/ritonavir and a rtemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-per iod, randomized trial,” Hiv Medicine, vol. 14, no. 7, pp. 421–429, 2013. View at Publisher · View at Google Scholar
  • Ke Li, Ling Tian, Yanli Luo, Qian Huang, Min Wang, and Ling Zhou, “Molecular markers of therapeutic resistance in breast cancer,” Human Pathology, vol. 44, no. 7, pp. 1421–1428, 2013. View at Publisher · View at Google Scholar
  • Monika E. Freiser, Paolo Serafini, and Donald T. Weed, “The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities,” Immunologic Research, 2013. View at Publisher · View at Google Scholar
  • Mika Okazawa, Seiji Mabuchi, Fumiaki Isohashi, Osamu Suzuki, Yasuo Yoshioka, Tomoyuki Sasano, Yukinobu Ohta, Shoji Kamiura, Kazuhiko Ogawa, and Tadashi Kimura, “Impact of the Addition of Concurrent Chemotherapy to Pelvic Radiotherapy in Surgically Treated Stage IB1-IIB Cervical Cancer Patients With Intermediat e-Risk or High-Risk Factors A 13-Year Experience,” International Journal of Gynecological Cancer, vol. 23, no. 3, pp. 567–575, 2013. View at Publisher · View at Google Scholar
  • Alberto Antonicelli, Stefano Cafarotti, Alice Indini, Alessio Galli, Andrea Russo, Alfredo Cesario, Filippo Maria Lococo, Patrizia Russo, Alberto Franco Mainini, Luca Giuseppe Bonifati, Mario Nosotti, Luigi Santambrogio, Stefano Margaritora, Pierluigi Maria Granone, and Andre Emanuel Dutly, “EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogen ic Mutation,” International Journal Of Medical Sciences, vol. 10, no. 3, pp. 320–330, 2013. View at Publisher · View at Google Scholar